KoreConX and Medtech-Ecosystem Together at LSI Emerging Medtech Summit 2022

by | Wednesday February 23, 2022
KoreConX and Medtech-Ecosystem Together at LSI Emerging Medtech Summit 2022

Experts in the life sciences sector will teach investors how to use Regulation A+ for successful capital raising

 

KoreConX is thrilled to announce its participation at LSI Emerging Medtech Summit – USA 2022. This event will be held on March 15-18, 2022, in Dana Point, California, USA. It is led by Life Science Intelligence (LSI) and will bring together an ecosystem of experts who support medtech and life science companies to raise capital.

LSI is part of the Medtech ecosystem of KoreConX’s partners focused on Life Sciences companies. LSI offers insights to help investors and executives make decisions based on data provided by experts on their team. This vertical includes Medical Funding Professionals, a company that specializes in consulting to raise capital for pharmaceutical and medical businesses.

The group has built a value-added offering around Regulation A+ fundraising they call the Capital Planning Valuation Strategy™ (CPVS). The purpose of the CPVS approach, beyond a successful Reg A+ raise, is to help companies develop a strategic plan for their long-term capital needs that protects the interests of the founders and other early investors as these capital-intensive businesses go through R&D, clinical trials, FDA approval, and go-to-market execution.

Stephen Brock, CEO of Medical Professionals, highlights the impact of this sector: “One of the major trends in the financial world right now is impact investing. Life science—medtech, biotech, and pharma—is the ultimate impact investment. These companies are saving lives and limbs and brains—saving quality of life, as well. That’s why we do what we do.”

“In the many years I’ve been working with medtech innovators, I can’t count the number of great products I’ve seen that never make it to market for no other reason than lack of access to capital. That’s why I’m so excited about the possibility Reg A+ brings—with the new higher limits,” says Scott Pantel, CEO of LSI.

This vertical includes  FINRA Broker-Dealer (Rialto Markets), Offering Preparation (Regulation D Resources) and KoreConX, with its All-In-One Platform to support all stages of the offerings.

This team will be together at LSI Emerging Medtech Summit 2022 and attendees can participate in person or online. KoreConX will be represented by its Co-founder and CEO, Oscar A Jofre; its Chief Scientist & CTO, Dr. Kiran Garimella; and its CRO, Peter Daneyko. Visit their website for more information:  https://www.lifesciencemarketresearch.com/medtech-summit-2022

About KoreConX

Founded in 2016, KoreConX is the first secure, All-In-One platform that manages private companies’ capital market activity and stakeholder communications. With an innovative approach and to ensure compliance with securities regulations and corporate law, KoreConX offers a single environment to connect companies to the capital markets and now secondary markets. Additionally, investors, broker-dealers, law firms, accountants and investor acquisition firms, all leverage our eco-system solution.

###

Media Contacts:
KoreConX
Carolina Casimiro
carolina@koreconx.com

Join the all-in-one platform empowering private capital markets.

Free forever, KoreConX makes it easy for participants in private capital markets to manage their investment portfolios, raise capital, and meet global compliance standards along every step of the way.

Book a demo
Join the All-In-One Platform empowering private capital markets.

Free forever, KoreConX makes it easy for participants in private capital markets to manage their investment portfolios, raise capital, and meet global compliance standards along every step of the way.